SCHEMBL29298620

SCHEMBL29298620

c1ccc(-c2ccc(-c3nc(-c4ccc5ccccc5c4)nc(-c4cc(-c5ccccc5)c5oc6cc7ccccc7cc6c5c4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
PGR P06401 1/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 2/20 0.33
NUDT1 P36639 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29298619 0.99 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL29298633 0.98 ALDH1A1 (0.38) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL26416164 0.98 KDM4E (0.41) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL29298634 0.98 ALDH1A1 (0.38) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL24586855 0.98 KDM4E (0.38) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL24586852 0.97 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL29298623 0.96 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL24585735 0.96 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL29298621 0.95 KDM4E (0.36) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL24585641 0.95 KDM4E (0.41) ALDH1A1MEN1KMT2AKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER CYP1A1, CYP1B1, CYP2E1 ALDH1A1 16/4885MEN1 338/4885KMT2A 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.